Search research articles
Contact Us
Filters
Showing results (11-20 of 64) with videos related to
Page
of 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma
E Wibe, E Hannisdal, E Paus, et al.
International Journal of Cancer
|
April 15, 1986
Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors
S Aamdal, O Fodstad, O Kaalhus, et al.
Journal of the National Cancer Institute
|
September 1, 1984
Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle
S Aamdal, O Fodstad, O Kaalhus, et al.
British Journal of Cancer
|
March 1, 1985
Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice
S Aamdal, O Fodstad, J M Nesland, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
March 21, 2001
[Gene therapy in cancer]
E Hovig, O Myklebost, S Aamdal, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1995
Serum levels of cytokines and soluble cytokine receptors in patients with metastatic renal cell carcinoma or malignant melanoma receiving IL-2/interferon-alpha combination therapy
S D Fosså, S Aamdal, B Naume, et al.
Cancer Research
|
April 1, 1985
Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas
O Fodstad, S Aamdal, A Pihl, et al.
British Journal of Cancer
|
June 1, 1990
Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients
T Tefre, A L Børresen, S Aamdal, et al.
Oncology Research
|
January 1, 1994
Clinical studies with EO9, a new indoloquinone bioreductive alkylating cytotoxic agent. EORTC Early Clinical Trials Group
J Verweij, S Aamdal, J Schellens, et al.
The British Journal of Radiology
|
October 1, 1993
A double blind study to evaluate the tolerability of gadodiamide injection and its effect on renal function in patients undergoing cerebral magnetic resonance imaging
B Lundby, K J Berg, H H Lien, et al.
Page
of 7
Search research articles
Search
Showing results (11-20 of 64) with videos related to
Sort By:
Page
of 7
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1992
Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma
E Wibe, E Hannisdal, E Paus, et al.
International Journal of Cancer
|
April 15, 1986
Chemosensitivity profiles of human cancers assessed by the 6-day SRC assay on serially xenografted tumors
S Aamdal, O Fodstad, O Kaalhus, et al.
Journal of the National Cancer Institute
|
September 1, 1984
Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle
S Aamdal, O Fodstad, O Kaalhus, et al.
British Journal of Cancer
|
March 1, 1985
Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice
S Aamdal, O Fodstad, J M Nesland, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|
March 21, 2001
[Gene therapy in cancer]
E Hovig, O Myklebost, S Aamdal, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1995
Serum levels of cytokines and soluble cytokine receptors in patients with metastatic renal cell carcinoma or malignant melanoma receiving IL-2/interferon-alpha combination therapy
S D Fosså, S Aamdal, B Naume, et al.
Cancer Research
|
April 1, 1985
Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas
O Fodstad, S Aamdal, A Pihl, et al.
British Journal of Cancer
|
June 1, 1990
Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients
T Tefre, A L Børresen, S Aamdal, et al.
Oncology Research
|
January 1, 1994
Clinical studies with EO9, a new indoloquinone bioreductive alkylating cytotoxic agent. EORTC Early Clinical Trials Group
J Verweij, S Aamdal, J Schellens, et al.
The British Journal of Radiology
|
October 1, 1993
A double blind study to evaluate the tolerability of gadodiamide injection and its effect on renal function in patients undergoing cerebral magnetic resonance imaging
B Lundby, K J Berg, H H Lien, et al.
Page
of 7